Skip to main content
logo
Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.6510
+0.0263 (4.21%)
Jul 28, 2026, 10:37 AM EDT - Market open

Aprea Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.120.291.50.58--
Revenue Growth
-90.40%-80.98%157.63%---
Gross Profit
0.120.291.50.58--
Operating Income
-12.58-13.23-14.32-15.47-113.39-37.45
Net Income
-11.95-12.6-12.96-14.29-112.66-37.13
Earnings Per Share
-1.54-1.93-2.35-3.95-67.99-34.88
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
46.4714.622.8521.6128.7953.08
Total Debt
000000.19
Net Cash (Debt)
46.4714.622.8521.6128.7952.89
Net Cash Growth
141.06%-36.11%5.75%-24.94%-45.57%-40.37%
Net Cash Per Share
5.342.234.155.9717.3749.69

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-12.02-12.89-13.56-12.18-25.01-37.69
Capital Expenditures
---0.02-0.09--
Free Cash Flow
-12.02-12.89-13.57-12.27-25.01-37.69
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%--
Operating Margin
-10202.00%-4631.12%-953.00%-2652.80%--
Pretax Margin
-9696.04%-4409.16%-862.43%-2449.59%--
Profit Margin
-9696.04%-4409.16%-862.43%-2449.59%--
FCF Margin
-9748.90%-4512.35%-903.26%-2103.92%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
62.7424.4612.0030.11--